Submitted by Anonymous (not verified) on 22 September 2023 - 12:08
Human medicines European public assessment report (EPAR): Adcirca (previously Tadalafil Lilly), tadalafil, Hypertension, Pulmonary, Date of authorisation: 01/10/2008, Revision: 17, Status: Authorised
Source: